An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Withdrawn before enrolling · Phase 3

Conditions studied: Hypogonadism, Testosterone Deficiency

In brief

This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.

Key facts

Study ID

NCT02082197

Run by

AbbVie

People needed

0

Starts

2014-03-01

Expected to finish

2015-06-01

Last updated by the study team

2014-06-02

Who can join

Age: 18 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Low testosterone

You may not qualify if…

• Normal testosterone levels
• Elevated Prostatic Specific Antigen (PSA)
• History of breast or prostate cancer

Where it is running

• Site Reference ID/Investigator# 124163 — Birmingham, Alabama, United States
• Site Reference ID/Investigator# 123938 — Huntsville, Alabama, United States
• Site Reference ID/Investigator# 125782 — Mesa, Arizona, United States
• Site Reference ID/Investigator# 124157 — Phoenix, Arizona, United States
• Site Reference ID/Investigator# 123937 — Tucson, Arizona, United States
• Site Reference ID/Investigator# 123948 — Anaheim, California, United States
• Site Reference ID/Investigator# 124164 — Los Angeles, California, United States
• Site Reference ID/Investigator# 123920 — Los Gatos, California, United States
• Site Reference ID/Investigator# 124038 — Colorado Springs, Colorado, United States
• Site Reference ID/Investigator# 126202 — Denver, Colorado, United States
• Site Reference ID/Investigator# 123927 — Middlebury, Connecticut, United States
• Site Reference ID/Investigator# 123947 — Clearwater, Florida, United States
• Site Reference ID/Investigator# 123929 — Jacksonville, Florida, United States
• Site Reference ID/Investigator# 123940 — Ocala, Florida, United States
• Site Reference ID/Investigator# 124166 — Orlando, Florida, United States
• Site Reference ID/Investigator# 123945 — Ponte Vedra Beach, Florida, United States
• Site Reference ID/Investigator# 123930 — Dunwoody, Georgia, United States
• Site Reference ID/Investigator# 124395 — Wichita, Kansas, United States
• Site Reference ID/Investigator# 125784 — Crestview Hills, Kentucky, United States
• Site Reference ID/Investigator# 123919 — Lexington, Kentucky, United States
• Site Reference ID/Investigator# 123925 — Baltimore, Maryland, United States
• Site Reference ID/Investigator# 123936 — Methuen, Massachusetts, United States
• Site Reference ID/Investigator# 124160 — Las Vegas, Nevada, United States
• Site Reference ID/Investigator# 123939 — Las Vegas, Nevada, United States
• Site Reference ID/Investigator# 123932 — Lawrenceville, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.